Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Broad Microbial Contamination Detection on one platform with results within 8 hours

Product Description

The Abbott PLEX-ID system is the only high-throughput technology that offers rapid, broad identification of known or unknown emerging organisms direct from sample, without the need for culture, enrichment or staining.

The PLEX-ID system provides the ability to screen for thousands of  adventitious agents, such as bacteria, fungi or viruses, in a single analysis with access to results within 8 hours from preparation to identification.  The PLEX-ID is commonly used during the Biopharmaceutical manufacturing process to test for Cell banking, thru to in-process testing and environmental monitoring.

The PLEX-ID technology uses broad PCR coupled with Mass Spectrometer detection to detect and determine the base composition of amplified primer pairs (amplicons) that are used to interrogate conserved regions that flank variable regions of highly conserved genes. The base composition determined for each amplicons is then searched against a database to determine the organisms present. This multilocus approach provides the ability to distinguish between closely related species as well as identify single nucleotide polymorphisms or mutations.

This Technology is not approved for use in diagnostic procedures.

Product Broad Microbial Contamination Detection on one platform with results within 8 hours
Company Abbott Laboratories – Ibis Biosciences Business Unit
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Abbott Laboratories – Ibis Biosciences Business Unit
2251 Faraday avenue, Suite 150 Carlsbad Ca 92008 USA

Tel: Sandrine.miller@abbott.com

Email: Sandrine.miller@abbott.com



Scientific News
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
Researchers Discover New Type of Mycovirus
Virus infects the fungus Aspergillus fumigatus, which can cause the human disease aspergillosis.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!